Allergan Acquisition Spree? Some Potential Big TargetsMark Melin
The aftermath of the Allergan divestiture and acquisition event is currently being digested by Wall Street, because the repercussions are likely to be larger than just the single day news. The move by Allergan is a transformative shift and an RBC Capital Markets research note looks at what could become a major trend. What could surprise institutional investors, the analysis notes, is the size of the acquisition spree.
RBC: “Investors legitimately believe that the Allergan deal… is a sign that it is theoretically possible that large-cap . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.